Skip to content

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Facial Basal Cell Carcinomas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02579551
Enrollment
179
Registered
2015-10-19
Start date
2011-12-07
Completion date
2017-05-04
Last updated
2025-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Basal Cell Carcinoma

Brief summary

This clinical trial studies the effectiveness of narrow margins in patients with low-risk basal cell carcinoma undergoing surgery to remove skin lesions on the face. A margin is the area of normal tissue around a tumor taken out during surgery to make sure all of the cancer is removed. This clinical trial studies tissue samples to determine the least amount of tissue that must be removed to give an acceptable cure rate. This may allow less normal tissue to be removed from patients and may be a less expensive surgery.

Detailed description

PRIMARY OBJECTIVES: I. To determine the success rate of narrow margin excisions of low-risk facial basal cell carcinoma (BCC). SECONDARY OBJECTIVES: I. To determine the narrowest excision margin for low-risk facial BCC that gives an acceptable (95%) cure rate over a 3 year follow-up period.

Interventions

PROCEDURETherapeutic Conventional Surgery

Undergo surgical excision

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Location 1. Area M (cheeks, forehead, scalp & neck) tumor size \< 10 mm 2. Area H (central face, eyelids, eyebrows, periorbital, nose, lips, chin, mandible, preauricular & postauricular, temple & ear) tumor size \< 6 mm 2. Well-defined borders 3. Primary BCC 4. Patient is not immunosuppressed 5. There has not been prior radiotherapy to the site 6. Nodular subtype 7. No perineural involvement-(no neurological deficits grossly) -

Exclusion criteria

1. Location 1. Area M tumor size \> or = to 10 mm 2. Area H tumor size \> or = to 6 mm 2. Poorly defined borders 3. Recurrent BCC 4. Patient is immunosuppressed 5. There has been prior radiotherapy to the site -

Design outcomes

Primary

MeasureTime frameDescription
Success rate for 1 mm marginsUp to 3 yearsThe success rate for 1 mm margin will be calculated along with an exact one-sided 95% confidence interval for the proportion. The success rate will be compared to a null value of 90% using a one-sided exact test of binomial proportion.
Success rate for 2 mm marginsUp to 3 yearsThe success rate for 2 mm margin will be calculated along with an exact one-sided 95% confidence interval for the proportion. The success rate will be compared to a null value of 90% using a one-sided exact test of binomial proportion.

Secondary

MeasureTime frame
Recurrence rate after 3 yearsUp to 3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026